These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 4944409

  • 1. Relief of anxiety and related emotions in patients with gastrointestinal disorders. A double-blind controlled study.
    Deutsch EM.
    Am J Dig Dis; 1971 Dec; 16(12):1091-4. PubMed ID: 4944409
    [No Abstract] [Full Text] [Related]

  • 2. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D, Manieri L, Mariano P.
    Arch Sci Med (Torino); 1980 Dec; 137(3):461-6. PubMed ID: 6112973
    [No Abstract] [Full Text] [Related]

  • 3. [Gefarnax in the treatment of gastrointestinal diseases of psychosomatic origin].
    Bianchi A, Scanni A, Giorgi-Conciato M.
    Minerva Gastroenterol; 1972 Dec; 18(3):175-81. PubMed ID: 4614115
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Action of the bromazepam-propantheline combination in patients with organic and functional gastrointestinal disorders].
    Laghi-Pasini F.
    Clin Ter; 1977 Nov 15; 83(3):301-11. PubMed ID: 23917
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Controlled therapeutic trial of gastroenteric diseases with psychogenic interference].
    Malaguti P.
    Minerva Med; 1970 Feb 17; 61(11):479-84. PubMed ID: 5416957
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test].
    Tanaka H, Takayama I, Ookubo N, Yoshimuta S, Kono Y.
    Saishin Igaku; 1970 May 17; 25(5):1128-36. PubMed ID: 4912179
    [No Abstract] [Full Text] [Related]

  • 14. [Double-blind study on the activity of RO 10-9618 (bromazepam and propantheline) in organic and functional disturbances of the gastrointestinal apparatus].
    Destito D, Tentori-Montalto T.
    Clin Ter; 1976 Jul 15; 78(1):57-63. PubMed ID: 12905
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Application of the neuroleptic pimozide (ORAP-R 6238) for tranquilizer indications in a controlled study.
    Pöldinger W.
    Int Pharmacopsychiatry; 1976 Jul 15; 11(1):16-24. PubMed ID: 770363
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Camazepam versus diazepam: a double-blind trial on psychoneurotic patients.
    Deberdt R.
    Curr Ther Res Clin Exp; 1975 Jan 15; 17(1):32-9. PubMed ID: 237742
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.